Business

iTeos Therapeutics (NASDAQ:ITOS) has been making significant strides in the field of immunotherapy, focusing on a molecule targeting TIGIT, a checkpoint with a complex...

Blue Bird Corporation Stock Analysis: Pricing and Backlog Driving Growth (NASDAQ: BLBD)After a successful 2023 driven by a strong demand environment for Blue Bird...

The upcoming week is set to be a crucial one for investors, with major events and announcements that could have a significant impact on...

Investing Strategy: Seizing Opportunities in the Market with PDI (NYSE:PDI)Have you ever found yourself in a situation where having the right tools or resources...

Enbridge Preferred Shares Offering 8.65% Yield: A Closer Look at Series 4 (NYSE:ENB)Preferred shares in Canada offer investors a unique opportunity to invest in...

Navigating Economic Uncertainty: The Impact of Recession vs. Stagflation on the MarketAs the labor market continues to show signs of weakening, it becomes evident...

BNY Mellon Global Stock Fund Q2 2024 Review and AnalysisGlobal equity markets experienced a rise this quarter, but beneath the surface, there was significant...

**Signet Jewelers Stock Surges with Strong Full-Year Guidance**Last month, I wrote an article praising Signet Jewelers Limited (NYSE: SIG) as a strong earner and...

**Dutch Bros Vs. Starbucks: A Battle of the Coffee Titans**In the competitive world of coffee chains, two giants stand out: Dutch Bros Inc. and...

**Top Dividend Stocks to Avoid in SCHD Portfolio**The Schwab U.S. Dividend Equity ETF (SCHD) is a popular investment option that tracks the Dow Jones...